WASHINGTON - Is a drug that might lower the risk of colon cancer worth taking if it also raises the risk of heart problems?
Two studies on the arthritis drug Celebrex found that the drug cut the chances of developing precancerous growths called polyps by 33 percent to 45 percent in people who already had such growths removed.
However, experts said the extra heart problems seen in those taking the drug mean that it can't be recommended for preventing cancer in people at average or slightly higher risk.
"We are all concerned about cardiovascular events," said Dr. Nadir Arber of Tel Aviv Sourasky Medical Center in Israel, who led one of the studies. …
No comments:
Post a Comment